Back to 
Qube Research & Technologies Ltd
Qube Research & Technologies Ltd
SMMT
Showing 0 of 5 quarters
Position history for Qube Research & Technologies Ltd's holdings in Summit Therapeutics Inc.
No. Qube Research & Technologies exited its SMMT (Summit Therapeutics) position in Q2 2023. Its Q1 2023 13F listed 34,906 shares worth $61,086. Qube Research & Technologies first reported SMMT in Q2 2022 and held it in 3 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of SMMT: Baker Bros. Advisors LP